1-4 of 4
S Bajaj
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antifibrinolytic Efficacy of Truncated L17R Mutant of Kunitz Domain 1 (KD1) of Tissue Factor Pathway Inhibitor-2 (TFPI-2): Comparison with Lysine Analogues

Madhu S Bajaj, Yogesh Kumar, Godwin I Ogueli, Kanagasabai Vadivel, Amy E Schmidt, Nalaka Rannulu, Joseph Loo, S. Paul Bajaj
Journal: Blood
Blood (2011) 118 (21): 855.
https://doi.org/10.1182/blood.V118.21.855.855
Published: 2011
Journal Articles

Mg 2+ Is Required for Optimal Folding of the γ-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca 2+

Kanagasabai Vadivel, Sayeh Agah, Amanda S. Messer, Duilio Cascio, Madhu S Bajaj, Sriram Krishnaswamy, Charles T Esmon, Kaillathe Padmanabhan, S. Paul Bajaj
Journal: Blood
Blood (2011) 118 (21): 1172.
https://doi.org/10.1182/blood.V118.21.1172.1172
Published: 2011
Journal Articles

Engineering Kunitz Domain of Human Tissue Factor Pathway Inhibitor-2 to Selectively Inhibit Fibrinolysis: An Antifibrinolytic Agent with Potential to Replace Aprotinin

Madhu S Bajaj, Godwin I Ogueli, Amy E Schmidt, Sreejesh Shanker, S. Paul Bajaj
Journal: Blood
Blood (2008) 112 (11): 24.
https://doi.org/10.1182/blood.V112.11.24.24
Published: 2008
Journal Articles

Adenosine and adenosine analogues are more toxic to chronic lymphocytic leukemia than to normal lymphocytes

S Bajaj, J Insel, F Quagliata, R Hirschhorn, R Silber
Journal: Blood
Blood (1983) 62 (1): 75–80.
https://doi.org/10.1182/blood.V62.1.75.75
Published: 1983